These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1310495)

  • 1. Potentiation of radiation response in human carcinoma cells in vitro and murine fibrosarcoma in vivo by topotecan, an inhibitor of DNA topoisomerase I.
    Kim JH; Kim SH; Kolozsvary A; Khil MS
    Int J Radiat Oncol Biol Phys; 1992; 22(3):515-8. PubMed ID: 1310495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of topoisomerase I inhibitors with radiation in cis-diamminedichloroplatinum(II)-sensitive and -resistant cells in vitro and in the FSAIIC fibrosarcoma in vivo.
    Boscia RE; Korbut T; Holden SA; Ara G; Teicher BA
    Int J Cancer; 1993 Jan; 53(1):118-23. PubMed ID: 8416195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addition of a topoisomerase I inhibitor to trimodality therapy [cis-diamminedichloroplatinum(II)/heat/radiation] in a murine tumor.
    Teicher BA; Holden SA; Khandakar V; Herman TS
    J Cancer Res Clin Oncol; 1993; 119(11):645-51. PubMed ID: 8394365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiosensitization of two murine fibrosarcomas with 6-thioguanine.
    Kim JH; Alfieri AA; Kim SH; Hong SS
    Int J Radiat Oncol Biol Phys; 1990 Mar; 18(3):583-6. PubMed ID: 2318691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential of topoisomerase I inhibitors in the treatment of CNS malignancies: report of a synergistic effect between topotecan and radiation.
    Lamond JP; Mehta MP; Boothman DA
    J Neurooncol; 1996 Oct; 30(1):1-6. PubMed ID: 8864997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic cell killing by ionizing radiation and topoisomerase I inhibitor topotecan (SK&F 104864).
    Mattern MR; Hofmann GA; McCabe FL; Johnson RK
    Cancer Res; 1991 Nov; 51(21):5813-6. PubMed ID: 1657371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation of murine MCa-4 carcinoma radioresponse by 9-amino-20(S)-camptothecin.
    Kirichenko AV; Rich TA; Newman RA; Travis EL
    Cancer Res; 1997 May; 57(10):1929-33. PubMed ID: 9157987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor activity of 7-[2-(N-isopropylamino)ethyl]-(20S)-camptothecin, CKD602, as a potent DNA topoisomerase I inhibitor.
    Lee JH; Lee JM; Kim JK; Ahn SK; Lee SJ; Kim MY; Jew SS; Park JG; Hong CI
    Arch Pharm Res; 1998 Oct; 21(5):581-90. PubMed ID: 9875499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of antitumor alkylating agents by novobiocin, topotecan, and lonidamine.
    Schwartz GN; Teicher BA; Eder JP; Korbut T; Holden SA; Ara G; Herman TS
    Cancer Chemother Pharmacol; 1993; 32(6):455-62. PubMed ID: 8258194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA topoisomerase I-targeting drugs as radiation sensitizers.
    Chen AY; Choy H; Rothenberg ML
    Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):39-46. PubMed ID: 10550825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA topoisomerase I poisons.
    Takimoto CH; Kieffer LV; Kieffer ME; Arbuck SG; Wright J
    Cancer Chemother Biol Response Modif; 1999; 18():81-124. PubMed ID: 10800479
    [No Abstract]   [Full Text] [Related]  

  • 12. [Topoisomerase I inhibitor with potential radiosensitizing effect].
    Sauer R; Heuser A
    Strahlenther Onkol; 1997 Mar; 173(3):125-30. PubMed ID: 9122851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of ionizing radiation with topotecan in two human tumor cell lines.
    Marchesini R; Colombo A; Caserini C; Perego P; Supino R; Capranico G; Tronconi M; Zunino F
    Int J Cancer; 1996 May; 66(3):342-6. PubMed ID: 8621255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic effect of combination topotecan and chronomodulated radiation therapy on xenografted human nasopharyngeal carcinoma.
    Zhang Y; Chen X; Ren P; Su Z; Cao H; Zhou J; Zou X; Fu S; Lin S; Fan J; Yang B; Sun X; Zhou Y; Chen Y; Yang L; Wu J
    Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):356-62. PubMed ID: 23906928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic efficacy of the topoisomerase I inhibitor 7-ethyl-10-(4-[1-piperidino]-1-piperidino)-carbonyloxy-camptothecin against human tumor xenografts: lack of cross-resistance in vivo in tumors with acquired resistance to the topoisomerase I inhibitor 9-dimethylaminomethyl-10-hydroxycamptothecin.
    Houghton PJ; Cheshire PJ; Hallman JC; Bissery MC; Mathieu-Boué A; Houghton JA
    Cancer Res; 1993 Jun; 53(12):2823-9. PubMed ID: 8504425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo activity of topotecan against human B-lineage acute lymphoblastic leukemia cells.
    Uckun FM; Stewart CF; Reaman G; Chelstrom LM; Jin J; Chandan-Langlie M; Waddick KG; White J; Evans WE
    Blood; 1995 May; 85(10):2817-28. PubMed ID: 7742543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concentration and timing dependence of lethality enhancement between topotecan, a topoisomerase I inhibitor, and ionizing radiation.
    Lamond JP; Wang M; Kinsella TJ; Boothman DA
    Int J Radiat Oncol Biol Phys; 1996 Sep; 36(2):361-8. PubMed ID: 8892461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topoisomerase I inhibitors in the combined-modality therapy of lung cancer.
    Cho LC; Choy H
    Oncology (Williston Park); 2004 Jun; 18(7 Suppl 4):29-39. PubMed ID: 15255165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor effect of DX-8951, a novel camptothecin analog, on human pancreatic tumor cells and their CPT-11-resistant variants cultured in vitro and xenografted into nude mice.
    Takiguchi S; Kumazawa E; Shimazoe T; Tohgo A; Kono A
    Jpn J Cancer Res; 1997 Aug; 88(8):760-9. PubMed ID: 9330608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of environmental conditions (pH, oxygenation, and temperature) on misonidazole cytotoxicity and radiosensitization in vitro and in vivo in FSaIIC fibrosarcoma.
    Holden SA; Teicher BA; Herman TS
    Int J Radiat Oncol Biol Phys; 1991 May; 20(5):1031-8. PubMed ID: 2022503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.